Immunomodulation of Human Blood Cells Following the Ingestion of Lactic Acid Bacteria
Open Access
- 1 March 1995
- journal article
- clinical trial
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 78 (3) , 491-497
- https://doi.org/10.3168/jds.s0022-0302(95)76659-0
Abstract
Because of the lack of data that convincingly show immunomodulatory properties of lactic acid bacteria in humans, a study was performed in which healthy volunteers were divided into two groups and given a fermented milk product supplemented with Lactobacillus acidophilus strain La1 or Bifidobacterium bifidum strain Bb 12 for 3 wk. Blood was sampled throughout the study to assess changes in lymphocyte subsets or leukocyte phagocytic activity following consumption of the fermented products. No modifications of lymphocyte subpopulations were detected. In contrast, phagocytosis of Escherichia coli sp. in vitro was enhanced after the administration of both fermented products. The increment in phagocytosis was coincident with fecal colonization by the lactic acid bacteria and persisted for 6 wk after ingestion of the fermented products. By this time, the fecal lactobacilli and bifidobacteria had returned to concentrations prior to consumption. Nonspecific, anti-infective mechanisms of defense can be enhanced by the ingestion of specific lactic acid bacteria strains. These strains can be used as nutritional supplements to improve the immune function of particular age groups, i.e., the neonate or the elderly, for which these functions are diminished.Keywords
This publication has 22 references indexed in Scilit:
- Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intakeFEMS Immunology & Medical Microbiology, 1994
- Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria.Gut, 1994
- Induction of human cytokines by bacteria used in dairy foodsNutrition Research, 1993
- Lactococcus lactis: high‐level expression of tetanus toxin fragment C and protection against lethal challengeMolecular Microbiology, 1993
- CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functionsClinical and Experimental Immunology, 1993
- Endogenous production of tumor necrosis factor in normal mice orally treated with deodan — A preparation from Lactobacillus bulgaricus “LB51”International Journal of Immunopharmacology, 1992
- Intra-epithelial lymphocytes: interferon-gamma production and suppressor/cytotoxic activitiesClinical and Experimental Immunology, 1990
- Oral administration of TNP-Lactobacillus conjugates in mice: A model for evaluation of mucosal and systemic immune responses and memory formation elicited by transformed lactobacilliResearch in Microbiology, 1990
- Enhancement of Immune Response of Murine Peyer's Patches by a Diet Supplemented With YogurtImmunopharmacology and Immunotoxicology, 1987
- Stimulation of non-specific resistance to infections by synthetic immunoregulatory agentsInfection, 1984